Patents by Inventor Lisa Bond Moritz

Lisa Bond Moritz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
    Patent number: 11814361
    Abstract: BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
    Type: Grant
    Filed: July 21, 2021
    Date of Patent: November 14, 2023
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa McKerracher, Lisa Bond Moritz
  • Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
    Patent number: 11701366
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Grant
    Filed: December 7, 2020
    Date of Patent: July 18, 2023
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Steven Wayne Riesinger, Lisa McKerracher, Lisa Bond Moritz
  • RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF
    Publication number: 20220089567
    Abstract: BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
    Type: Application
    Filed: July 21, 2021
    Publication date: March 24, 2022
    Applicant: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. ROSEN, Matthew D. ABBINANTI, Joerg RUSCHEL, Lisa MCKERRACHER, Lisa BOND MORITZ
  • Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
    Patent number: 11198680
    Abstract: BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
    Type: Grant
    Filed: January 6, 2020
    Date of Patent: December 14, 2021
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa McKerracher, Lisa Bond Moritz
  • TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSMS WITH RHO KINASE INHIBITORS
    Publication number: 20210290635
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Application
    Filed: December 7, 2020
    Publication date: September 23, 2021
    Inventors: Kenneth M. ROSEN, Steven Wayne RIESINGER, Lisa MCKERRACHER, Lisa BOND MORITZ
  • Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
    Patent number: 10857157
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Grant
    Filed: December 10, 2018
    Date of Patent: December 8, 2020
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Steven Wayne Riesinger, Lisa McKerracher, Lisa Bond Moritz
  • RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF
    Publication number: 20200199105
    Abstract: BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
    Type: Application
    Filed: January 6, 2020
    Publication date: June 25, 2020
    Inventors: Kenneth M. ROSEN, Matthew D. ABBINANTI, Joerg RUSCHEL, Lisa MCKERRACHER, Lisa BOND MORITZ
  • Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
    Patent number: 10526313
    Abstract: BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: January 7, 2020
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa Mckerracher, Lisa Bond Moritz
  • TREATMENT OF CEREBRAL CAVERNOUS MALFORMATIONS AND CEREBRAL ANEURYSMS WITH RHO KINASE INHIBITORS
    Publication number: 20190298733
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Application
    Filed: December 10, 2018
    Publication date: October 3, 2019
    Inventors: Kenneth M. ROSEN, Steven Wayne RIESINGER, Lisa MCKERRACHER, Lisa BOND MORITZ
  • Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
    Patent number: 10149856
    Abstract: Provided are methods of treating a cerebral cavernous malformation (CCM) and methods of treating cerebral aneurysm in a mammal with certain rho kinase inhibitors.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: December 11, 2018
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Steven Wayne Riesinger, Lisa McKerracher, Lisa Bond Moritz
  • Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
    Patent number: 10106525
    Abstract: The disclosure provides rho kinase inhibitor BA-1049(R), an hydroxy metabolite of BA-1049(R), and adipate salts and deuterated forms thereof, useful for treating CNS disorders and injuries.
    Type: Grant
    Filed: May 9, 2017
    Date of Patent: October 23, 2018
    Assignee: BioAxone BioSciences, Inc.
    Inventors: Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa Mckerracher, Lisa Bond Moritz
  • RHO KINASE INHIBITOR BA-1049 (R) AND ACTIVE METABOLITES THEREOF
    Publication number: 20180297982
    Abstract: BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.
    Type: Application
    Filed: May 24, 2018
    Publication date: October 18, 2018
    Inventors: Kenneth M. Rosen, Matthew D. Abbinanti, Joerg Ruschel, Lisa Mckerracher, Lisa Bond Moritz